- Home
- ZBIO vs DRDB Comparison
ZBIO vs DRDB Comparison
Compare ZBIO & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- DRDB
- Stock Information
- Founded
- ZBIO 2019
- DRDB 2024
- Country
- ZBIO United States
- DRDB United States
- Employees
- ZBIO N/A
- DRDB N/A
- Industry
- ZBIO
- DRDB
- Sector
- ZBIO
- DRDB
- Exchange
- ZBIO NYSE
- DRDB Nasdaq
- Market Cap
- ZBIO 389.2M
- DRDB 315.6M
- IPO Year
- ZBIO 2024
- DRDB 2024
- Fundamental
- Price
- ZBIO $10.19
- DRDB $10.32
- Analyst Decision
- ZBIO Strong Buy
- DRDB
- Analyst Count
- ZBIO 7
- DRDB 0
- Target Price
- ZBIO $32.29
- DRDB N/A
- AVG Volume (30 Days)
- ZBIO 207.1K
- DRDB 111.0K
- Earning Date
- ZBIO 08-16-2025
- DRDB 01-01-0001
- Dividend Yield
- ZBIO N/A
- DRDB N/A
- EPS Growth
- ZBIO N/A
- DRDB N/A
- EPS
- ZBIO N/A
- DRDB N/A
- Revenue
- ZBIO $15,000,000.00
- DRDB N/A
- Revenue This Year
- ZBIO $206.00
- DRDB N/A
- Revenue Next Year
- ZBIO $41.92
- DRDB N/A
- P/E Ratio
- ZBIO N/A
- DRDB $591.83
- Revenue Growth
- ZBIO N/A
- DRDB N/A
- 52 Week Low
- ZBIO $5.83
- DRDB $9.87
- 52 Week High
- ZBIO $26.25
- DRDB $10.43
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- DRDB N/A
- Support Level
- ZBIO N/A
- DRDB N/A
- Resistance Level
- ZBIO N/A
- DRDB N/A
- Average True Range (ATR)
- ZBIO 0.00
- DRDB 0.00
- MACD
- ZBIO 0.00
- DRDB 0.00
- Stochastic Oscillator
- ZBIO 0.00
- DRDB 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.